Contemporary treatment of hypertrophic cardiomyopathy

Review

. 2009;36(3):194-204.

Contemporary treatment of hypertrophic cardiomyopathy

Ali J Marian¹

Affiliations

Affiliation

¹ Center for Cardiovascular Genetics, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center, and Texas Heart Institute at St. Luke's Episcopal Hospital, Houston, Texas 77030, USA. Ali.J.Marian@uth.tmc.edu

PMID: 19568388
PMCID: PMC2696493

Review

Contemporary treatment of hypertrophic cardiomyopathy

Ali J Marian. Tex Heart Inst J. 2009.

. 2009;36(3):194-204.

Author

Ali J Marian¹

Affiliation

¹ Center for Cardiovascular Genetics, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center, and Texas Heart Institute at St. Luke's Episcopal Hospital, Houston, Texas 77030, USA. Ali.J.Marian@uth.tmc.edu

PMID: 19568388
PMCID: PMC2696493

No abstract available

Keywords: Athletic performance; cardiomegaly/genetics; cardiomyopathy, hypertrophic, familial/genetics; cardiomyopathy, hypertrophic/diagnosis/pathology/therapy; catheter ablation/adverse effects; death, sudden, cardiac/epidemiology/etiology/prevention & control; defibrillators, implantable; disease models, animal; genetic predisposition to disease; heart septum; phenotype; risk factors; treatment outcome.

PubMed Disclaimer

Cited by

Preventative therapeutic approaches for hypertrophic cardiomyopathy.
Solomon T, Filipovska A, Hool L, Viola H. Solomon T, et al. J Physiol. 2021 Jul;599(14):3495-3512. doi: 10.1113/JP279410. Epub 2020 Sep 7. J Physiol. 2021. PMID: 32822065 Free PMC article. Review.
Disease modeling of a mutation in α-actinin 2 guides clinical therapy in hypertrophic cardiomyopathy.
Prondzynski M, Lemoine MD, Zech AT, Horváth A, Di Mauro V, Koivumäki JT, Kresin N, Busch J, Krause T, Krämer E, Schlossarek S, Spohn M, Friedrich FW, Münch J, Laufer SD, Redwood C, Volk AE, Hansen A, Mearini G, Catalucci D, Meyer C, Christ T, Patten M, Eschenhagen T, Carrier L. Prondzynski M, et al. EMBO Mol Med. 2019 Dec;11(12):e11115. doi: 10.15252/emmm.201911115. Epub 2019 Nov 3. EMBO Mol Med. 2019. PMID: 31680489 Free PMC article.
Fropofol prevents disease progression in mice with hypertrophic cardiomyopathy.
Huang Y, Lu H, Ren X, Li F, Bu W, Liu W, Dailey WP, Saeki H, Gabrielson K, Abraham R, Eckenhoff R, Gao WD. Huang Y, et al. Cardiovasc Res. 2020 May 1;116(6):1175-1185. doi: 10.1093/cvr/cvz218. Cardiovasc Res. 2020. PMID: 31424496 Free PMC article.
Ultrasonic Cavitation-Enabled Treatment for Therapy of Hypertrophic Cardiomyopathy: Proof of Principle.
Miller DL, Lu X, Dou C, Zhu YI, Fuller R, Fields K, Fabiilli ML, Owens GE, Gordon D, Kripfgans OD. Miller DL, et al. Ultrasound Med Biol. 2018 Jul;44(7):1439-1450. doi: 10.1016/j.ultrasmedbio.2018.03.010. Epub 2018 Apr 19. Ultrasound Med Biol. 2018. PMID: 29681423 Free PMC article.
Multiple ultrasound cavitation-enabled treatments for myocardial reduction.
Miller DL, Lu X, Dou C, Zhu YI, Fabiilli ML, Owens GE, Kripfgans OD. Miller DL, et al. J Ther Ultrasound. 2017 Nov 9;5:29. doi: 10.1186/s40349-017-0107-x. eCollection 2017. J Ther Ultrasound. 2017. PMID: 29152303 Free PMC article.

See all "Cited by" articles

References

1. Liouville H. Retrecissement cardiaque, sous-aortique. Gazette Medicale de Paris 1869;24:161–5.
1. Schmincke A. Ueber linkseitige muskulose conusstenosen. Dtsch Med Wochenschr 1907;33:2082–3.
1. Braunwald E, Ebert PA. Hemodynamic alterations in idiopathic hypertrophic subaortic stenosis induced by sympathomimetic drugs. Am J Cardiol 1962;10:489–95. - PubMed
1. Braunwald E, Lambrew CT, Rockoff SD, Ross J Jr, Morrow AG. Idiopathic hypertrophic subaortic stenosis. I. A description of the disease based upon an analysis of 64 patients. Circulation 1964;30:Suppl 4:3–119. - PubMed
1. Morrow AG, Lambrew CT, Braunwald E. Idiopathic hypertrophic subaortic stenosis. II. Operative treatment and the results of pre- and postoperative hemodynamic evaluations. Circulation 1964;30:Suppl 4:120–51. - PubMed

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- Genetic Alliance
- MedlinePlus Health Information

[1] Liouville H. Retrecissement cardiaque, sous-aortique. Gazette Medicale de Paris 1869;24:161–5.

[2] Liouville H. Retrecissement cardiaque, sous-aortique. Gazette Medicale de Paris 1869;24:161–5.

[3] Schmincke A. Ueber linkseitige muskulose conusstenosen. Dtsch Med Wochenschr 1907;33:2082–3.

[4] Schmincke A. Ueber linkseitige muskulose conusstenosen. Dtsch Med Wochenschr 1907;33:2082–3.

[5] Braunwald E, Ebert PA. Hemodynamic alterations in idiopathic hypertrophic subaortic stenosis induced by sympathomimetic drugs. Am J Cardiol 1962;10:489–95. - PubMed

[6] Braunwald E, Ebert PA. Hemodynamic alterations in idiopathic hypertrophic subaortic stenosis induced by sympathomimetic drugs. Am J Cardiol 1962;10:489–95. - PubMed

[7] Braunwald E, Lambrew CT, Rockoff SD, Ross J Jr, Morrow AG. Idiopathic hypertrophic subaortic stenosis. I. A description of the disease based upon an analysis of 64 patients. Circulation 1964;30:Suppl 4:3–119. - PubMed

[8] Braunwald E, Lambrew CT, Rockoff SD, Ross J Jr, Morrow AG. Idiopathic hypertrophic subaortic stenosis. I. A description of the disease based upon an analysis of 64 patients. Circulation 1964;30:Suppl 4:3–119. - PubMed

[9] Morrow AG, Lambrew CT, Braunwald E. Idiopathic hypertrophic subaortic stenosis. II. Operative treatment and the results of pre- and postoperative hemodynamic evaluations. Circulation 1964;30:Suppl 4:120–51. - PubMed

[10] Morrow AG, Lambrew CT, Braunwald E. Idiopathic hypertrophic subaortic stenosis. II. Operative treatment and the results of pre- and postoperative hemodynamic evaluations. Circulation 1964;30:Suppl 4:120–51. - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Contemporary treatment of hypertrophic cardiomyopathy

Affiliation

Contemporary treatment of hypertrophic cardiomyopathy

Author

Affiliation

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical